455 related articles for article (PubMed ID: 29655215)
21. Expression of thymus and activation-regulated chemokine (TARC) by human dermal cells, but not epidermal keratinocytes.
Shoda T; Futamura K; Kobayashi F; Saito H; Matsumoto K; Matsuda A
J Dermatol Sci; 2014 Nov; 76(2):90-5. PubMed ID: 25219597
[TBL] [Abstract][Full Text] [Related]
22. Effects of tumor necrosis factor-α, interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis.
Takamura S; Takahashi A; Inoue Y; Teraki Y
J Dermatol; 2018 Sep; 45(9):1130-1134. PubMed ID: 30004583
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis.
Gu CY; Gu L; Dou X
Int J Dermatol; 2015 Jul; 54(7):e261-5. PubMed ID: 26108268
[TBL] [Abstract][Full Text] [Related]
24. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
[TBL] [Abstract][Full Text] [Related]
25. Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO).
Pinter A; Eyerich K; Costanzo A; Garrelts A; Schuster C; Mert C; Lampropoulou A; Fotiou K; Maul JT; Papp KA
J Dermatolog Treat; 2024 Dec; 35(1):2350227. PubMed ID: 38797734
[TBL] [Abstract][Full Text] [Related]
26. The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity.
Wu LT; Qiao ZH; Tian JB; Lin JL; Hou SC; Liu XM
Skin Res Technol; 2023 Jul; 29(7):e13405. PubMed ID: 37522491
[TBL] [Abstract][Full Text] [Related]
27. Secukinumab (AIN457) for the treatment of psoriasis.
López-Ferrer A; Vilarrasa E; Puig L
Expert Rev Clin Immunol; 2015; 11(11):1177-88. PubMed ID: 26428036
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
Gan EY; Chong WS; Tey HL
BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
[TBL] [Abstract][Full Text] [Related]
29. Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab.
Morita A; Tani Y; Matsumoto K; Yamaguchi M; Teshima R; Ohtsuki M
J Dermatol; 2020 May; 47(5):452-457. PubMed ID: 32173900
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis.
Green LJ; Yamauchi PS; Kircik LH
J Drugs Dermatol; 2019 Aug; 18(8):776-788. PubMed ID: 31424708
[TBL] [Abstract][Full Text] [Related]
31. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
32. Cultivated ginseng inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice and TNF-α/IFN-γ-induced TARC activation in HaCaT cells.
Choi JH; Jin SW; Park BH; Kim HG; Khanal T; Han HJ; Hwang YP; Choi JM; Chung YC; Hwang SK; Jeong TC; Jeong HG
Food Chem Toxicol; 2013 Jun; 56():195-203. PubMed ID: 23454147
[TBL] [Abstract][Full Text] [Related]
33. Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.
Furue M; Matsumoto T; Yamamoto T; Takeuchi S; Esaki H; Chiba T; Yamaguchi H
J Dermatol Sci; 2012 Apr; 66(1):60-3. PubMed ID: 22391243
[TBL] [Abstract][Full Text] [Related]
34. Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
Pinter A; Puig L; Schäkel K; Reich A; Zaheri S; Costanzo A; Tsai TF; Smith SD; Lynde C; Brnabic A; Reed C; Hill J; Schuster C; Riedl E; Paul C
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2087-2100. PubMed ID: 35766124
[TBL] [Abstract][Full Text] [Related]
35. IL-17A Inhibitor Switching - Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience.
Sherman S; Solomon Cohen E; Amitay-Laish I; Hodak E; Pavlovsky L
Acta Derm Venereol; 2019 Jul; 99(9):769-773. PubMed ID: 31017250
[TBL] [Abstract][Full Text] [Related]
36. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis.
Kataoka Y
J Dermatol; 2014 Mar; 41(3):221-9. PubMed ID: 24628072
[TBL] [Abstract][Full Text] [Related]
37. Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation.
Galluzzo M; Talamonti M; De Simone C; D'Adamio S; Moretta G; Tambone S; Caldarola G; Fargnoli MC; Peris K; Bianchi L
Expert Opin Biol Ther; 2018 Jul; 18(7):727-735. PubMed ID: 29798698
[TBL] [Abstract][Full Text] [Related]
38. The TNF/IL-23/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment.
Ten Bergen LL; Petrovic A; Krogh Aarebrot A; Appel S
Scand J Immunol; 2020 Oct; 92(4):e12946. PubMed ID: 32697374
[TBL] [Abstract][Full Text] [Related]
39. Thymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease.
Machida H; Inoue S; Shibata Y; Kimura T; Sato K; Abe K; Murano H; Yang S; Nakano H; Sato M; Nemoto T; Sato C; Nishiwaki M; Yamauchi K; Igarashi A; Tokairin Y; Watanabe M
Allergol Int; 2021 Jan; 70(1):81-88. PubMed ID: 32444304
[TBL] [Abstract][Full Text] [Related]
40. [Clinical experience with etanercept in the treatment of psoriasis].
Martín B; Sánchez-Carazo JL; Pérez-Ferriols A; Laguna C; Oliver V; Alegre V
Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
